KPTI Financials
Karyopharm Therapeutics Inc - Financial statements & key metrics
Stock Price
$8.45
Market Cap
$186.66M
EPS
$-17.93
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$145.24M
Gross Profit
-
Operating Income
-
Net Income
$-76.42M
EPS (Diluted)
$-0.93
Balance Sheet Highlights
Total Assets
$164.42M
Total Liabilities
$350.44M
Shareholders Equity
-
Cash & Equivalents
$62.48M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-127.49M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
9.9%
Operating Margin
-0.5%
Net Margin
-1.3%
ROE
-8.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KPTI revenue?
KPTI's most recent quarterly revenue was $145.24M. Annual revenue can be calculated by summing the four most recent quarters.
Is KPTI profitable?
KPTI reported a loss of $76.42M in the most recent quarter. The net profit margin is -1.3%.
What is KPTI market cap?
KPTI has a market capitalization of $186.66M, making it a small-cap stock.
Does KPTI have debt?
View KPTI's balance sheet for debt information.
What is KPTI cash flow?
Cash flow data is available in the full financial statements.